Application Area

The University of Texas System is a leading public university system in the United States, dedicated to improving lives through education, health care, and research. With over 256,000 students enrolled across 14 institutions, the UT System is committed to providing affordable access to higher education and producing a skilled workforce to drive Texas's economy.

Able Hands Rehabilitation, established in 1994, is a leading provider of hand therapy services with a focus on personalized care. With locations in Old Bridge, Freehold, and Edison, NJ, the company specializes in treating hand injuries and impairments through a combination of occupational and physical therapy. Their mission is to deliver high-quality hand therapy in a friendly and informal setting, earning the trust of hand surgeons and patients alike. They are recognized for their innovative approaches, including the development of custom splints and braces using advanced technology.

SIMETRI is a woman-and-minority owned small business based in Winter Park, Florida, specializing in modeling, simulation, and training technologies. Founded in 2009, the company focuses on delivering innovative products and services that enhance the human experience and improve client outcomes through advanced training and program management analysis.

Texas Tech University (TTU) is a leading public research university located in Lubbock, Texas. With a commitment to providing a diverse and inclusive education, TTU offers over 150 undergraduate and 104 graduate programs across various fields. The university emphasizes innovation, research, and community engagement, aiming to empower students to become world-changers and leaders in their respective fields. As a Carnegie Tier One Research Institution and a Hispanic-Serving Institution, TTU is dedicated to fostering an environment that promotes inclusive access while attracting committed and high-achieving students. TTU has a vibrant campus life, with over 600 student organizations and a strong focus on student wellness and support. The university is also recognized for its significant contributions to research and community outreach, including initiatives like the Thoma Scholars Program for rural students and the Institute for Critical Infrastructure Security. Recently, the opening of the Cash Family Ranch Life Learning Center has further enhanced TTU's commitment to education and community engagement, providing immersive experiences related to ranching and agriculture.

The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization dedicated to advancing the bioeconomy of the United States. Its mission encompasses enhancing manufacturing, healthcare, and education and workforce development, aiming to create a scalable and effective manufacturing ecosystem for engineered cells, tissues, and organs.

Georgia Southern University is a vibrant institution with over 26,100 students across three campuses in Statesboro, Savannah, and Hinesville. The university offers 132 degree programs at the associate, bachelor’s, master’s, and doctorate levels, emphasizing student success, community impact, and research excellence. With a commitment to inclusivity and engagement, Georgia Southern fosters a supportive environment for diverse learners, including military-affiliated and adult students. The university is dedicated to transforming lives through education and community engagement, aligning its programs with regional needs. Additionally, Georgia Southern provides accelerated pathways for students to fast-track their master's degrees, enhancing educational opportunities. The university also emphasizes career readiness and public impact research, preparing students for successful careers and contributing to community development.

Vascarta Inc. is a pharmaceutical company that has developed a patented topical/transdermal delivery platform aimed at improving the bioavailability of drugs, particularly curcumin, a compound known for its anti-inflammatory and antioxidant properties. The company focuses on addressing unmet medical needs through innovative formulations that enhance therapeutic efficacy and patient outcomes.

Stream Biomedical, Inc. is a clinical-stage biopharmaceutical company focused on developing first-in-class targeted therapeutics for acute neurotrauma and chronic neurodegenerative diseases. The company is dedicated to revolutionizing cerebrovascular repair and developing novel solutions for neurotrauma and neurodegeneration, including conditions such as stroke, traumatic brain injury, and Alzheimer's disease.

Founded in 1960 by Dr. Joseph V. Brady, the Institutes for Behavior Resources, Inc. (IBR) is a nonprofit organization dedicated to enhancing the growth of behavioral sciences and their application to human affairs through research, clinical services, and educational initiatives. IBR focuses on addressing social challenges through innovative research and comprehensive health services.

At LMI, we’re reimagining the path from insight to outcome at The New Speed of Possible™. Combining a legacy of over 60 years of federal expertise with our innovation ecosystem, we minimize time to value and accelerate mission success. We energize the brightest minds with emerging technologies to inspire creative solutioning and push the boundaries of capability. LMI advances the pace of progress, enabling our customers to thrive while adapting to evolving mission needs. We are committed to investing over $1,000,000 annually in training, development, and tuition assistance for our staff, ensuring our team remains at the forefront of innovation.

FluidForm Bio™ is revolutionizing medicine through its patented FRESH™ technology, which enables the bioprinting of living human tissue for advanced cell therapy and disease treatment. Founded in 2018, the company integrates innovations in 3D printing, synthetic biology, and AI to create tissue that closely resembles natural human tissue, aiming to improve patient outcomes and transform healthcare.

LumenAstra, Inc. is at the forefront of developing innovative, wearable, non-invasive sensors for accurately measuring internal body temperatures. Originating from a need identified by DARPA to protect troops from heat stress, the company collaborates with the University of Colorado's Radio Frequency Lab to commercialize a patented technology. This technology, initially used for astronomical measurements, is now being adapted to monitor critical health parameters such as brain and tumor temperatures, promising to revolutionize medical monitoring and treatment.

Humanetics Corporation is a clinical-stage pharmaceutical company based in Minneapolis, Minnesota, focused on developing and commercializing products to enhance human health and wellbeing. Founded in 1988, the company specializes in radiation modulators, adjunctive oncology therapies, and pulmonary protective therapies, particularly for COVID-19. Humanetics is known for its lead drug candidate, BIO 300, which is being developed as a radioprotectant for military and civilian use, as well as a treatment to improve outcomes in cancer patients receiving radiotherapy. The company is actively engaged in research programs for non-small cell lung cancer, prostate cancer, and head and neck cancers.

DePuy Synthes, the Orthopaedics Company of Johnson & Johnson, is dedicated to keeping people moving through innovations in orthopaedic surgery, support, and education. With a comprehensive portfolio in joint reconstruction, trauma, craniomaxillofacial, spinal surgery, and sports medicine, DePuy Synthes aims to advance patient care while delivering clinical and economic value to healthcare systems worldwide.

NervGen Pharma Corp is a clinical-stage biotech company focused on developing innovative treatments to enable nervous system repair in cases of traumatic injury and disease. Their lead drug candidate, NVG-291, is currently being evaluated in a Phase 1b/2a clinical trial for spinal cord injury, with additional preclinical evaluations for conditions such as ischemic stroke and amyotrophic lateral sclerosis (ALS). The company is also advancing a new development candidate, NVG-300, in preclinical studies.

Teleflex is a global provider of medical technologies designed to improve the health and quality of people's lives. The company focuses on purpose-driven innovation to empower healthcare professionals and enhance patient outcomes across various medical fields.